Understanding SARS-CoV-2-Mediated Inflammatory Responses: From

Currently there is no effective antiviral therapy for SARS-CoV-2 infection, which frequently leads to fatal inflammatory responses and acute lung injury. Here, we discuss the various mechanisms of SARS-CoV-mediated inflammation. We also assume that SARS-CoV-2 likely shares similar inflammatory responses. Potential therapeutic tools to reduce SARS-CoV-2-induced inflammatory responses include various methods to block FcR activation. In the absence of a proven clinical FcR blocker, the use of intravenous immunoglobulin to block FcR activation may be a viable option for the urgent treatment of pulmonary inflammation to prevent severe lung injury. Such treatment may also be combined with systemic anti-inflammatory drugs or corticosteroids. However, these strategies, as proposed here, remain to be clinically tested for effectiveness.

Autoimmunity and Inflammation

Testing Host Immune Responses and Transmissibility

SARS-CoV-2 Initiates Programmed Cell Death in Platelets

Post-acute sequelae of COVID-19: understanding and addressing the burden of multisystem manifestations - The Lancet Respiratory Medicine

Blocking Immune System Pathway May Stop COVID-19 Infection, Prevent Severe Organ Damage

Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools

Cell‐mediated immunity to SARS‐CoV‐2 - Wang - 2020 - Pediatric Investigation - Wiley Online Library

New research supports finding explaining why some patients may test positive for COVID-19 long after recovery

SARS-CoV-2 couples evasion of inflammatory response to activated nucleotide synthesis

Small NIH study reveals how immune response triggered by COVID-19 may damage the brain

What is the role of T cells in COVID-19 infection? Why immunity is about more than antibodies - The Centre for Evidence-Based Medicine

Eje Renina Angiotensina, Enzima Convertidora de Angiotensina 2 y Coronavirus

Full article: Short- and potential long-term adverse health outcomes of COVID-19: a rapid review

Potential role of platelets in COVID‐19: Implications for thrombosis - Research and Practice in Thrombosis and Haemostasis

A Possible Role for Anti-idiotype Antibodies in SARS-CoV-2 Infection and Vaccination